Microbiological testing is reasonably spread around the world, testing practices within various geographic regions vary significantly. Automation provides significant time and cost saving while also reducing the potential of human error. It also enables the provision of consistently reliable and accurate results. There are commercially available automated and semi-automated systems that are based on several technologies such as polymerase chain reaction (PCR), next-generation sequencing (NGS), MALDI-TOF mass spectrometry, flow cytometry, bioluminescence technology, and enzyme-linked fluorescent assay (ELFA). Most of these technologies are aimed at providing efficiency gains when compared to traditional laboratory technologies, and therefore have significant potential for both time and cost savings. Hence, these technologies are adopted for the detection and identification of pathogens and other microorganisms in the manufacturing process of industries to avoid further chances of product recalls.
According to our latest research, the global Industrial Microbiological QC market size will reach USD million in 2028, growing at a CAGR of % over the analysis period.
Global Industrial Microbiological QC Scope and Market Size
This report focuses on the global Industrial Microbiological QC status, future forecast, growth opportunity, key market and key players. The study objectives are to present the Industrial Microbiological QC development in North America, Europe, Asia-Pacific, Latin America and Middle East & Africa, etc.
Segment by Type
PCR
Bioluminescence
Flow Cytometry
Membrane Filtration
Fluorescence
Colorimetry
Others
Segment by Application
Product Testing Laboratories
Research and Academic Institutions
Pharmaceutical and Biotechnology Companies
Regulatory and Environmental Agencies
Food and Beverage Companies
Others
By Region
North America
Europe
Asia-Pacific
Latin America
Middle East & Africa
By Company
3M Company
Becton, Dickinson and Company
Bio-Rad Laboratories
Biolog
bioMérieux
Bruker Corporation
BIOTECON Diagnostics GmbH
Charles River Laboratories International
Danaher Corporation
F. Hoffmann-La Roche Ltd.
R-Biopharm AG
Lonza Group AG
Merck KGaA
Novacyt S.A.
QIAGEN N.V.
Sartorius AG
Shimadzu Corporation
Thermo Fisher Scientific